139 related articles for article (PubMed ID: 29088718)
1. Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.
Liu P; Calvisi DF; Kiss A; Cigliano A; Schaff Z; Che L; Ribback S; Dombrowski F; Zhao D; Chen X
Oncotarget; 2017 Sep; 8(43):73433-73447. PubMed ID: 29088718
[TBL] [Abstract][Full Text] [Related]
2. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
[TBL] [Abstract][Full Text] [Related]
3. CDK9 is dispensable for YAP-driven hepatoblastoma development.
Chen X; Kiss A; Schaff Z; Evert K; Zhang Y; Zhong S; Wang J; Evert M; Calvisi DF; Chen X
Pediatr Blood Cancer; 2020 May; 67(5):e28221. PubMed ID: 32124532
[TBL] [Abstract][Full Text] [Related]
4. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
[TBL] [Abstract][Full Text] [Related]
5. Upregulated YAP promotes oncogenic CTNNB1 expression contributing to molecular pathology of hepatoblastoma.
Lu S; Jiang M; Chen Q; Luo X; Cao Z; Huang H; Zheng M; Du J
Pediatr Blood Cancer; 2022 Sep; 69(9):e29705. PubMed ID: 35404538
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
7. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.
Lu X; Peng B; Chen G; Pes MG; Ribback S; Ament C; Xu H; Pal R; Rodrigues PM; Banales JM; Evert M; Calvisi DF; Chen X; Fan B; Wang J
Am J Pathol; 2021 Sep; 191(9):1651-1667. PubMed ID: 34129844
[TBL] [Abstract][Full Text] [Related]
8. A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth.
Ong YT; Andrade J; Armbruster M; Shi C; Castro M; Costa ASH; Sugino T; Eelen G; Zimmermann B; Wilhelm K; Lim J; Watanabe S; Guenther S; Schneider A; Zanconato F; Kaulich M; Pan D; Braun T; Gerhardt H; Efeyan A; Carmeliet P; Piccolo S; Grosso AR; Potente M
Nat Metab; 2022 Jun; 4(6):672-682. PubMed ID: 35726026
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development.
Molina L; Yang H; Adebayo Michael AO; Oertel M; Bell A; Singh S; Chen X; Tao J; Monga SPS
Oncotarget; 2019 Feb; 10(15):1475-1490. PubMed ID: 30863496
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.
Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV
J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Yes-associated protein and transcriptional co-activator with PDZ-binding motif influences the behavior of LOVO human colon adenocarcinoma cells.
Li Y; Li L; Zhu M; Ye L; Yang Q
Exp Ther Med; 2017 Oct; 14(4):3831-3835. PubMed ID: 29042987
[TBL] [Abstract][Full Text] [Related]
12. TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis.
Wang S; Ma K; Chen L; Zhu H; Liang S; Liu M; Xu N
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515420
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Mutant Forms of NFE2L2/NRF2 Drive Aggressive Murine Hepatoblastomas.
Wang H; Lu J; Mandel JA; Zhang W; Schwalbe M; Gorka J; Liu Y; Marburger B; Wang J; Ranganathan S; Prochownik EV
Cell Mol Gastroenterol Hepatol; 2021; 12(1):199-228. PubMed ID: 33618031
[TBL] [Abstract][Full Text] [Related]
14. Phase separation of YAP mediated by coiled-coil domain promotes hepatoblastoma proliferation via activation of transcription.
Mao S; Liu Q; Wu H; Zhu J; Xie Y; Ma J; Zhen N; Pan Q
J Gastroenterol Hepatol; 2023 Aug; 38(8):1398-1407. PubMed ID: 36908026
[TBL] [Abstract][Full Text] [Related]
15. Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers.
Oku Y; Nishiya N; Shito T; Yamamoto R; Yamamoto Y; Oyama C; Uehara Y
FEBS Open Bio; 2015; 5():542-9. PubMed ID: 26199863
[TBL] [Abstract][Full Text] [Related]
16. Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolism.
Jeon HY; Choi J; Kraaier L; Kim YH; Eisenbarth D; Yi K; Kang JG; Kim JW; Shim HS; Lee JH; Lim DS
EMBO J; 2022 Apr; 41(8):e109365. PubMed ID: 35285539
[TBL] [Abstract][Full Text] [Related]
17. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease.
Wang K; Degerny C; Xu M; Yang XJ
Biochem Cell Biol; 2009 Feb; 87(1):77-91. PubMed ID: 19234525
[TBL] [Abstract][Full Text] [Related]
18. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
[TBL] [Abstract][Full Text] [Related]
19. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
20. miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells.
Higashi T; Hayashi H; Ishimoto T; Takeyama H; Kaida T; Arima K; Taki K; Sakamoto K; Kuroki H; Okabe H; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
Br J Cancer; 2015 Jul; 113(2):252-8. PubMed ID: 26125451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]